Recent news on Ultrase

Axcan Pharma Continues Solid Growth in Fiscal 2007, With Record ...  -  May 10, 2007
CCNMatthews (press release),..."We also added momentum to our product pipeline by successfully launching PYLERA in the United States and finalizing the development of ULTRASE,

Strong Start for Axcan Pharma's Fiscal 2007, With Record Revenue ...  -  Feb 8, 2007
Genetic Engineering News (press release),Axcan is currently advancing the completion of the New Drug Application ("NDA") of ULTRASE and VIOKASE, and is on track to meet the deadline for NDA

Axcan Pharma Closes Fiscal 2006 with Record Annual Revenue of ...  -  Nov 30, 2006
Genetic Engineering News (press release),In April 2004, the FDA formally notified manufacturers of pancreatic insufficiency products that these drugs, which include VIOKASE and ULTRASE,

Axcan Pharma Closes Fiscal 2006 with Record Annual Revenue of ...  -  Nov 30, 2006
Genetic Engineering News (press release),In April 2004, the FDA formally notified manufacturers of pancreatic insufficiency products that these drugs, which include VIOKASE and ULTRASE,

Axcan Announces Strong Third Quarter 2006 Revenue of $76.7 Million ...  Aug 10, 2006
In April 2004, the FDA formally notified manufacturers of pancreatic insufficiency products that these drugs, which include VIOKASE and ULTRASE, must receive ... -Market Wire



Axcan announces record revenue of $72.8 million for the second ...  May 4, 2006
ULTRASE-VIOKASE In April 2004, the FDA formally notified manufacturers of pancreatic insufficiency products that these drugs must receive approval before April ... - Canada NewsWire

Axcan announces record revenue of $72.8 million for the second ...  May 4, 2006
Additional studies on ULTRASE are currently carried on and anticipated to be completed and results submitted along with other clinical and Chemistry ... - Yahoo! News

/FIRST AND FINAL ADD - MO124- AXCAN PHARMA INC./  May 4, 2006
...had been named along with other third parties, as defendants in several legal proceedings related to the product line it markets under the name ULTRASE. ... - PR Newswire





Axcan announces record revenue of $70.6 million for the first ...  Feb 9, 2006
Additional studies on ULTRASE are in process and anticipated to be completed and submitted along with other clinical and CMC data in the form of a New Drug ... - Yahoo! News

Axcan announces record revenue of $70.6 million for the first ...  09 Feb 2006
ULTRASE-VIOKASE In April 2004, the Food and Drug Administration formally notified manufacturers of pancreatic insufficiency products that these drugs must ... - PR Newswire

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional